about
Detecting tumor progression in glioma: Current standards and new techniques.Image-guided adaptive radiation therapy (IGART): Radiobiological and dose escalation considerations for localized carcinoma of the prostate.Evaluation of image-guided radiation therapy (IGRT) technologies and their impact on the outcomes of hypofractionated prostate cancer treatments: a radiobiologic analysis.Radiopharmaceuticals for the palliation of painful bone metastasis-a systemic review.Nontraumatic osteonecrosis after chemotherapy for testicular cancer: a systematic review.A statistical comparison of prognostic index systems for brain metastases after stereotactic radiosurgery or fractionated stereotactic radiation therapy.Preservation of memory with conformal avoidance of the hippocampal neural stem-cell compartment during whole-brain radiotherapy for brain metastases (RTOG 0933): a phase II multi-institutional trial.The use of conformal radiotherapy and the selection of radiation dose in T1 or T2 low or intermediate risk prostate cancer - a systematic review.Duration of androgen suppression before radiotherapy for localized prostate cancer: radiation therapy oncology group randomized clinical trial 9910.CT perfusion imaging as an early biomarker of differential response to stereotactic radiosurgery in C6 rat gliomas.Radiotherapy for pediatric central nervous system tumors: a regional cancer centre experience.A phase II multi-institutional study assessing simultaneous in-field boost helical tomotherapy for 1-3 brain metastases.Evaluation of CT Perfusion Biomarkers of Tumor Hypoxia.Fitness to drive in patients with brain tumours: the influence of mandatory reporting legislation on radiation oncologists in Canada.Target margins in radiotherapy of prostate cancerTRIM59, a novel multiple cancer biomarker for immunohistochemical detection of tumorigenesis.Assessing fitness to drive in brain tumour patients: a grey matter of law, ethics, and medicine.CogState computerized memory tests in patients with brain metastases: secondary endpoint results of NRG Oncology RTOG 0933.On the performances of Intensity Modulated Protons, RapidArc and Helical Tomotherapy for selected paediatric cases18F-fluorocholine for prostate cancer imaging: a systematic review of the literature.Hypofractionated radiotherapy with or without concurrent temozolomide in elderly patients with glioblastoma multiforme: a review of ten-year single institutional experience.Prostate: registration of digital histopathologic images to in vivo MR images acquired by using endorectal receive coil.Intensity-modulated radiotherapy in the treatment of prostate cancer.Propensity-score matched pair comparison of whole brain with simultaneous in-field boost radiotherapy and stereotactic radiosurgery.Systematic review of brain metastases prognostic indices.Management of high-grade gliomas in the elderly.Patient- and family-centered care: a qualitative exploration of oncologist perspectives.Dynamic perfusion CT in brain tumors.A Phase 1/2 Trial of Brief Androgen Suppression and Stereotactic Radiation Therapy (FASTR) for High-Risk Prostate Cancer.Technology assessment of automated atlas based segmentation in prostate bed contouring.[(18)F]-DCFPyL Positron Emission Tomography/Magnetic Resonance Imaging for Localization of Dominant Intraprostatic Foci: First Experience.Searching for wisdom in oncology care: A scoping review.Enumerating pelvic recurrence following radical cystectomy for bladder cancer: A Canadian multi-institutional study.The significance of circulating tumor cells in prostate cancer patients undergoing adjuvant or salvage radiation therapy.Improving quantitative CT perfusion parameter measurements using principal component analysis.Relationship of computed tomography perfusion and positron emission tomography to tumour progression in malignant glioma.Novel application of helical tomotherapy in whole skull palliative radiotherapy.Lessons learned from reirradiation of recurrent skull base meningioma: A case report and review of the literature.Categorizing segmentation quality using a quantitative quality assurance algorithm.Evaluation of inter-fraction prostate motion using kilovoltage cone beam computed tomography during radiotherapy.
P50
Q31132701-1960975B-2BD2-43BF-AE6E-FB1DA3E5D3E9Q33222245-35FF7943-F957-4C1E-A932-FADA20F1FF60Q33230302-E10E40E7-A8D5-42D0-8965-F2C5D7038DD8Q33991574-F4B0E002-7031-4104-A38A-52C3F7D9685CQ34501082-D2DF074F-75A0-45DA-86EF-E45251BE157DQ34503353-DB50CD9D-CC96-49DC-A9D9-0A096DB2AD0FQ34551025-BD0D9308-037E-47A6-A915-BB9E4F4BAEEDQ34872147-079349EF-2CBB-4719-A234-D16D01C15C0CQ34996654-8B167412-841A-4912-9892-E7075C368CECQ35348742-47B0BDF0-C1CA-4C56-BB1A-01C8E690FF00Q35872783-87946444-7030-41A3-84DE-D30130598F99Q35925369-FEBB8FB0-FC66-4644-9D31-9BCA547989A6Q35990065-EA569753-AC84-4D2E-A3BE-5657CD32D4F6Q36000224-C32CBEFF-9532-423B-B3F7-8F6A1B22C618Q36067678-95FAC635-1114-476C-AC3C-693E7847096BQ36370301-B4294F32-7C79-4C28-8737-3F4260CE9D19Q36738530-2D7DD50E-D86D-4319-925B-1852A266E74FQ36965962-171CF411-561E-472C-8894-E1C4F70655D0Q37168668-D3B1C948-14F2-4284-BC41-48FCAC92EDDBQ37918311-82964E33-5655-461E-AE73-CBF0E13ADBFAQ37959367-1C66EF4E-7AE7-4546-A0CB-498F80BB5007Q37999806-1DD985DE-5A8D-4FB5-BAB4-0D53409D76E8Q38016727-242F7403-304D-4A17-ABB4-7A740E15894DQ38065546-63405A6E-F597-42ED-AC8E-7B20523284BCQ38199826-AA11E5B7-0282-4CCE-8246-64E3FFCA7F23Q38248995-AD998B74-8E8D-4FEB-A858-6FDD8A79D276Q38377452-F30408C1-0505-4BF9-BEBB-E344758346A6Q38386411-AF81FC87-24B8-4AB7-A618-4C1358AA43C2Q38455925-B347B5B4-F696-4165-9C81-704B4F92AAF4Q38563492-8B2F41D5-F3C3-451C-B380-3159A6A2282CQ38650299-9DA3327B-05F2-4554-A27C-BFAB86CB310EQ38817927-5AA2CE8B-BCB1-4B95-9E7A-091D49D83552Q38842793-F55C7EDE-EE7A-436F-B418-CAD966997D82Q38946933-12BE734A-F03A-4D54-9BDB-F6AF94B1D592Q39007687-C014EE24-0DB5-4571-81D7-31E6C80871A1Q39260129-AEC893C7-B5C4-4F67-9641-28175D2559FDQ39312579-BA79295F-1A7B-4CE8-BA59-F9007399D2F2Q39456183-AF260D39-B55B-4472-9953-DB516A186E95Q39508668-B604D555-E285-41B6-8541-AEBFD1008097Q39761751-59DEF102-928F-432B-96F3-235E5E363DDE
P50
description
hulumtues
@sq
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Glenn Bauman
@ast
Glenn Bauman
@en
Glenn Bauman
@es
Glenn Bauman
@nl
Glenn Bauman
@sl
type
label
Glenn Bauman
@ast
Glenn Bauman
@en
Glenn Bauman
@es
Glenn Bauman
@nl
Glenn Bauman
@sl
prefLabel
Glenn Bauman
@ast
Glenn Bauman
@en
Glenn Bauman
@es
Glenn Bauman
@nl
Glenn Bauman
@sl
P106
P1153
7005181837
P21
P2456
P31
P496
0000-0002-5279-7360